Thrombophilia Screening After Severe IUGR

Last updated: September 20, 2022
Sponsor: Central Hospital, Nancy, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pregnancy Complications

Blood Clots

Thrombosis

Treatment

N/A

Clinical Study ID

NCT05551078
2022PI102
  • Ages > 18
  • Female

Study Summary

This retrospective study aims to assess the input of thrombophilia screening in pregnant women with severe intra-uterine growth restricted babies.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Women over 18 years old
  • Pregnant women
  • IUGR defined by an EFW <3rd centile
  • IUGR before 25 GW

Exclusion

Exclusion Criteria:

  • none

Study Design

Total Participants: 100
Study Start date:
September 15, 2022
Estimated Completion Date:
January 31, 2023

Connect with a study center

  • Matthieu Dap

    Nancy, 54000
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.